| Young | Three years http://www.poly.ee/polygon/ bimatoprost 0.03 discontinued The company, which develops therapies based onplacenta-derived stem cells, said it received a U.S. patent forits methods in the treatment of peripheral artery disease - acondition in which blood vessels narrow, blocking the supply ofblood to arms and legs. |
|